Search scope:
排序: Display mode:
Frontiers of Medicine 2022, Volume 16, Issue 3, Pages 403-415 doi: 10.1007/s11684-021-0858-1
Keywords: myeloproliferative neoplasms IRF4 IRF8 hydroxyurea essential thrombocythemia
Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu
Frontiers of Medicine 2016, Volume 10, Issue 4, Pages 444-450 doi: 10.1007/s11684-016-0471-x
The incidence rate of pancreatic neuroendocrine neoplasms (pNENs) has increased rapidly in recent
Keywords: pancreatic neuroendocrine neoplasms clinicopathological characteristic Ki-67 liver metastasis outcomes
The clinicopathologic features of intraductal papillary mucinous neoplasms of the pancreas
QIN Xinyu, LIU Fenglin
Frontiers of Medicine 2007, Volume 1, Issue 2, Pages 121-125 doi: 10.1007/s11684-007-0023-5
Keywords: available additional existence necessitate intraductal papillary non-invasive
Small cell carcinoma of the urinary bladder without gross hematuria: a case report
Wanqiu Huang,Yang Luan,Lu Jin,Tao Wang,Ruibao Chen,Zheng Liu,Zhiqiang Chen,Ruzhu Lan
Frontiers of Medicine 2015, Volume 9, Issue 3, Pages 384-387 doi: 10.1007/s11684-015-0405-z
Small cell carcinoma of the urinary bladder (SCCB) is a rare and aggressive form of bladder cancer with poor prognosis. Hematuria is the main symptom of this malignancy, and most patients have a history of smoking. The disease incidence of malignant bladder tumors in China is approximately 0.74%. Early and accurate diagnosis of SCCB can ensure timely and appropriate treatment of this malignant disease. Oncologic surgery is the standard treatment; however, it may not be a curative approach. Chemotherapy and/or radiotherapy should be performed following surgical removal. This case report describes a patient with a single neoplasm diagnosed as SCCB that arose because of recurrence of bladder cancer after bladder tumor resection. In contrast to previously reported cases, this patient had no gross hematuria and no history of smoking.
Keywords: carcinoma small cell urinary bladder neoplasms diagnosis
Frontiers of Medicine Pages 907-923 doi: 10.1007/s11684-023-1009-7
Keywords: FAK6/7 SRRM4 neuroendocrine neoplasms pancreas breast
Expression of PC-cell-derived growth factor in breast cancer
Haiping SONG MD, Lan SHI MD, Chunping LIU MD, Tao HUANG MD,
Frontiers of Medicine 2009, Volume 3, Issue 4, Pages 426-430 doi: 10.1007/s11684-009-0085-7
Keywords: PC-cell-derived growth factor breast neoplasms clinical markers
Influence of the adjuvant therapy on the survival of patients with stage II pancreatic carcinoma
Xi-Yan WANG, Hai-Jun LI, Dong YAN, Hao WEN, Shu-Yong PENG,
Frontiers of Medicine 2010, Volume 4, Issue 4, Pages 430-435 doi: 10.1007/s11684-010-0700-7
Keywords: pancreatic neoplasms neoadjuvant therapy survival
Title Author Date Type Operation
IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia
Journal Article
Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological
Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu
Journal Article
The clinicopathologic features of intraductal papillary mucinous neoplasms of the pancreas
QIN Xinyu, LIU Fenglin
Journal Article
Small cell carcinoma of the urinary bladder without gross hematuria: a case report
Wanqiu Huang,Yang Luan,Lu Jin,Tao Wang,Ruibao Chen,Zheng Liu,Zhiqiang Chen,Ruzhu Lan
Journal Article
High frequency of alternative splicing variants of the oncogene in neuroendocrine tumors of the pancreas and breast
Journal Article
Expression of PC-cell-derived growth factor in breast cancer
Haiping SONG MD, Lan SHI MD, Chunping LIU MD, Tao HUANG MD,
Journal Article